Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure - A case report

被引:25
作者
Al-Khodairy, AT
Vuagnat, H
Uebelhart, D
机构
[1] Univ Hosp Geneva, Dept Clin Neurosci, Spinal Cord Unit, Geneva, Switzerland
[2] Univ Hosp Geneva, Div Phys Med & Rehabil, Dept Clin Neurosci, Geneva, Switzerland
[3] Rush Presbyterian St Lukes Med Ctr, Dept Biochem, Chicago, IL 60612 USA
关键词
spinal cord injuries; baclofen; substance withdrawal syndrome; implantable infusion pumps; spasticity;
D O I
10.1097/00002060-199905000-00018
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
A 24-yr-old, completely (T8) paraplegic male patient presenting with severe spasticity had a drug administration device implanted in April 1991 for continuous intrathecal administration of baclofen. After a period of remarkable improvement in both the spasticity level and his quality of life, the patient experienced several short-lasting episodes of increased spasticity, with severe spasms. Among the possible causes of these deleterious episodes were microcrystalluria, obstipation, a decubitus ulcer, a foreign body in the buttocks, drug tolerance to baclofen, electromagnetic interference, and erroneous filling and programing of the pump. The catheter was the most common source of intrathecal baclofen withdrawal symptoms and had to be changed four times in 5 yr. Intrathecal baclofen administered through an implantable drug administration device is a highly effective but complex and expensive procedure that requires careful patient selection and close monitoring by highly qualified and well-trained health professional. Withdrawal symptoms may be related to noncompliance on the part of the patient, erroneous filling or programing of the pump, depletion of the battery, random component failure, concomitant illness, drug tolerance, or advancement of the disease itself. When failure of the device is suspected, substitution with oral baclofen is recommended until a full work-up is performed to determine the defect.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 20 条
  • [11] CONTINUOUS INTRATHECAL BACLOFEN IN SPINAL-CORD SPASTICITY - A PROSPECTIVE-STUDY
    MEYTHALER, JM
    STEERS, WD
    TUEL, SM
    CROSS, LL
    HAWORTH, CS
    [J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1992, 71 (06) : 321 - 327
  • [12] INTRATHECAL BACLOFEN THERAPY FOR ADULTS WITH SPINAL SPASTICITY - THERAPEUTIC EFFICACY AND EFFECT ON HOSPITAL ADMISSIONS
    NANCE, P
    SCHRYVERS, O
    SCHMIDT, B
    DUBO, H
    LOVERIDGE, B
    FEWER, D
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (01) : 22 - 29
  • [13] ACCIDENTAL INTRASPINAL OVERDOSE REVISITED
    PATT, RB
    WU, C
    BRESSI, J
    CATANIA, JA
    [J]. ANESTHESIA AND ANALGESIA, 1993, 76 (01) : 202 - 202
  • [14] INTRATHECAL BACLOFEN FOR SPASTICITY OF SPINAL ORIGIN - 7 YEARS OF EXPERIENCE
    PENN, RD
    [J]. JOURNAL OF NEUROSURGERY, 1992, 77 (02) : 236 - 240
  • [15] CATHETER SYSTEMS FOR INTRATHECAL DRUG-DELIVERY
    PENN, RD
    YORK, MM
    PAICE, JA
    [J]. JOURNAL OF NEUROSURGERY, 1995, 83 (02) : 215 - 217
  • [16] INTRATHECAL BACLOFEN FOR SEVERE SPINAL SPASTICITY
    PENN, RD
    SAVOY, SM
    CORCOS, D
    LATASH, M
    GOTTLIEB, G
    PARKE, B
    KROIN, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (23) : 1517 - 1521
  • [17] ERRORS AND LIMITATIONS OF THE MULTIMODALITY CHECKING METHODS OF DEFECTIVE SPINAL INTRATHECAL PUMP SYSTEMS - CASE-REPORT
    SCHURCH, B
    [J]. PARAPLEGIA, 1993, 31 (09): : 611 - 615
  • [18] COMPLICATIONS OF INTRATHECAL BACLOFEN DELIVERY
    TEDDY, P
    JAMOUS, A
    GARDNER, B
    WANG, DJ
    SILVER, J
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 1992, 6 (02) : 115 - 118
  • [19] TSUI JKC, 1994, THERAPY BOTULINUM TO, P523
  • [20] Zierski J, 1988, Acta Neurochir Suppl (Wien), V43, P94